跳至主要内容
临床试验/NCT00771121
NCT00771121Unknown4 期

Effect of Moisturizing Creams on Skin Barrier Function

ACO Hud Nordic AB1 个研究点 分布在 1 个国家开始时间: 2008年10月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
试验地点
1

研究概览

简要总结

This study is a randomized, double-blind, placebo-controlled bilateral study on the effect of moisturizing creams on skin barrier function. The hypothesis is that a new active emulsion has a better influence on skin barrier function comapred to its placebo.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Dry skin barrier disorders such as atopic dermatitis or Malassezia eradicated head and neck dermatitis.
  • Rough or clinically normal skin on the volar aspect of the forearm.
  • Either gender
  • Age between 18 and 65 years
  • Written Informed Consent

排除标准

  • Possible allergy to ingredients in the study medications.
  • Use of any concomitant medication that may interfere with the study related activities or assessment of efficacy.
  • Any patient related factor suggesting potential poor compliance with study procedures (e.g. psychiatric disorders, history of alcohol or substance abuse).
  • Any serious medical condition which, in the opinion of the investigator, may interfere with the evaluation of the results.
  • Pregnancy or breast feeding, or patients who plan to become pregnant during the course of the study.

研究组 & 干预措施

new emulsion

Active Comparator

干预措施: urea/lactic acid (Drug)

new emulsion placebo

Placebo Comparator

干预措施: Placebo (Drug)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验